We could not find any results for:
Make sure your spelling is correct or try broadening your search.
PerkinElmer provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments: diagnostics, which includes immunodiagnostics, reproductive health, and applied genomics, and di... PerkinElmer provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments: diagnostics, which includes immunodiagnostics, reproductive health, and applied genomics, and discovery and analytical solutions, composed of life science, industrial, environmental, and food applications. PerkinElmer offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software. Show more
The Board of Directors of Revvity (NYSE: RVTY), today declared a regular quarterly dividend of $0.07 per share of common stock. This dividend is payable on August 9, 2024 to all shareholders of...
Revvity, Inc. (NYSE: RVTY) will present at the BofA Securities 2024 Health Care Conference on Tuesday, May 14, 2024 at 8:40 a.m. PT in Las Vegas, NV. Senior Vice President and Chief Financial...
New and improved workflow now available that pairs Revvity’s T-SPOT™.TB test with the Auto-Pure 2400 liquid handling platform Substantially lowers hands-on time, allowing for increased lab...
New CRO system-level expansion elevates data stewardship and enables organizations to gain more insight with less oversight Today, Revvity, Inc. (NYSE: RVTY) announced that its software and...
Revvity, Inc. (NYSE: RVTY), today announced that it will release its first quarter 2024 financial results prior to market open on Monday, April 29, 2024. The Company will host a conference call...
Today, Revvity, Inc. (NYSE: RVTY) announced that the Massachusetts Superior Court has granted a preliminary injunction compelling Cloud Software Group (CSG) to comply with its contractual...
Asserts CSG has acted in bad faith, ignoring obligations as strategic partner for Spotfire® software Today, Revvity, Inc. (NYSE: RVTY) announced that it has filed a complaint against Cloud...
— Next-generation suite enhances research productivity and innovation across chemical, pharmaceutical, and biotechnology industries and academia — Seamless integration within Revvity Signals...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 1.98 | 1.98496240602 | 99.75 | 104.05 | 99.51 | 687293 | 102.06659757 | CS |
4 | -3.27 | -3.11428571429 | 105 | 110.82 | 97.315 | 988623 | 104.51352899 | CS |
12 | -7.06 | -6.4895670558 | 108.79 | 111.18 | 97.315 | 853879 | 105.00336912 | CS |
26 | 2.31 | 2.32347616174 | 99.42 | 115 | 79.5 | 899207 | 100.49494661 | CS |
52 | -14.61 | -12.5580195977 | 116.34 | 132 | 79.5 | 816092 | 106.90371054 | CS |
156 | -14.61 | -12.5580195977 | 116.34 | 132 | 79.5 | 816092 | 106.90371054 | CS |
260 | -14.61 | -12.5580195977 | 116.34 | 132 | 79.5 | 816092 | 106.90371054 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions